Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Vaccine Development for Parasitic Disease"
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Attenuated/Inactivated/Live and Vectored Vaccines".
Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 3048
Special Issue Editors
Interests: Anaplasma; African swine fever virus
Interests: infectious diseases; vaccine development; microbiology and immunology; protein expression and purification
Special Issue Information
I am pleased to invite you to submit contributions to a Special Issue focused on human and veterinary vaccine research against well-known and emerging parasites that challenge human or animal health. We welcome articles on the development and evaluation of vaccines against parasitic infections. The scope of this Special Issue covers vaccine engineering, design, formulation, adjuvants, delivery and testing, as well as novel approaches to the discovery and characterization of antigens or small molecules that may be the foundation for novel therapeutics, and their associated immunological evaluations. The full experimental details must be provided so that the results can be reproduced, and any computed data or files regarding the full details of the experimental procedure can be deposited as Supplementary Materials.
I look forward to receiving your contributions.
Dr. Qingli Niu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- human vaccine
- veterinary vaccine
- human or animal health
- vaccine engineering
- novel therapeutics
- small molecules